(Q41533862)

2 October 2017

1 reference

title

Growth factors in human ovarian cancer (English)

1 reference

2 October 2017

1 reference

Westermann AM

1

1 reference

2 October 2017

Beijnen JH

series ordinal

2

1 reference

2 October 2017

Moolenaar WH

series ordinal

3

1 reference

2 October 2017

Rodenhuis S

series ordinal

4

1 reference

2 October 2017

1 March 1997

1 reference

2 October 2017

Cancer Treatment Reviews

1 reference

2 October 2017

23

1 reference

2 October 2017

113-131

1 reference

2 October 2017

2

1 reference

Two new tissue culture lines from ovarian cancer

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Characterization of an ovarian carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Characterization of two new human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Development and characterization of a human ovarian cancer cell line which clones without agar in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Characterization of newly established human ovarian carcinoma cell line--special reference of the effects of cis-platinum on cellular proliferation and release of CA125.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2 (Sf) growing in serum-free conditions: growth characteristics, biochemical, and cytogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

New human ovarian cell line OVCCR1/sf in serum-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Establishment and characterization of four human epithelial ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Regulation of metastatic ovarian cells in serum-free medium by epidermal growth factor and transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Extracellular matrix interactions. 1: Production of extracellular matrix with attachment and growth-sustaining functions by UWOV2 ovarian cancer cells growing in protein-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Modulation of human tumor colony growth in soft agar by serum

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Peptide growth factors are multifunctional

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Autocrine growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Effect of epidermal growth factor on clonogenic growth of primary human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Structure and function of human amphiregulin: a member of the epidermal growth factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

c-erbB growth-factor-receptor proteins in ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Absence of constitutive EGF receptor activation in ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Determination of transforming growth factor activity in effusions from cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

c-erbB-2 oncogene expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Receptors for the TGF-β family

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Extracellular matrix interactions. 2: Extracellular matrix structure is important for growth factor localization and function

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

The biology of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

The heparin-binding (fibroblast) growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Basic fibroblast growth factor and receptor expression in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Cytokines: From clone to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Epithelial ovarian cancer: a cytokine propelled disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

In situ detection of tumour necrosis factor in human ovarian cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Constitutive Production of Macrophage Colony-Stimulating Factor and Interleukin-6 by Human Ovarian Surface Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Immunoproliferation and cancer: a common macrophage-derived promoter substance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Human tumour clonogenicity in agar is improved by cell-free ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Identification of a tumor inhibitory factor in rat ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Platelet activating factor: a biologically active phosphoglyceride

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Platelet-activating factor: receptors and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Assembly of phospholipids into cellular membranes: biosynthesis, transmembrane movement and intracellular translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

LPA: a novel lipid mediator with diverse biological actions

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Influence of platelet lysate on colony formation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Effect of lysophospholipids on signaling in the human Jurkat T cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Lysophospholipids activate ovarian and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

Lysophosphatidic acid signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2897%2990024-4

7 January 2021

10.1016/S0305-7372(97)90024-4

Identifiers

DOI

1 reference

2 October 2017

1 reference